Business Context and Reporting Period
Company: Abbott Laboratories
Filing Type: Form 8-K (Current Report)
Date of Report: July 10, 2003
Reporting Period: Second Quarter of 2003
This filing serves as a current report announcing the results of operations for the second quarter of 2003. The detailed financial data is contained in a press release furnished as Exhibit 99.1 and incorporated by reference.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are located in the referenced press release (Exhibit 99.1) which is not included in the provided text.
The company utilizes the following non-GAAP financial measures to evaluate ongoing business performance:
- Net earnings excluding one-time charges
- Diluted earnings per share excluding one-time charges
- Gross margin excluding one-time charges
- Sales excluding the impact of foreign exchange
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to the incorporated press release for comparative analysis.
Guidance, Outlook, and Management Commentary
Management Commentary: Abbott's management believes that presenting non-GAAP financial measures provides useful information to investors by adjusting for factors that are unusual or unpredictable. These measures are also used internally to monitor business performance.
Cautionary Note: Management cautions investors to consider these non-GAAP measures in addition to, and not as a substitute for, financial measures prepared in accordance with GAAP.
Guidance and Risks: The filing text does not contain specific forward-looking guidance, risk factors, or details on contingencies beyond the general caution regarding non-GAAP measures.
Important Facts for Investor Verification
- Verify the specific GAAP and non-GAAP financial results in the press release (Exhibit 99.1) incorporated by reference.
- Confirm the magnitude of "one-time charges" excluded from the non-GAAP metrics to understand the impact on reported earnings.
- Assess the impact of foreign exchange on sales figures as noted in the non-GAAP adjustments.
- Review the full press release for any specific operational updates or segment performance details not summarized in this 8-K.